Chronic administration of B1R and B2R antagonist noscapine ameliorated amyloidosis-associated cerebral hypoperfusion and vascular reactivity, but did not affect Aβ cerebral load and associated microgliosis. The gene discussed is BDKRB1; the disease is amyloidosis.